CLINICAL_TRIALS
research
· 2010-01-01
Clinical Trial Update: Pilot Study of Apremilast (CC-10004) in the Treatment of Moderate to Severe Lichen Planus [Phase 2]
Summary
A Phase 2 pilot study is evaluating apremilast for moderate to severe lichen planus, with the trial status not disclosed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Virginia Clinical Research, Inc. | Conditions: Lichen Planus | Phase 2 | Status: UNKNOWN